OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting Treg signaling for the treatment of autoimmune diseases

HTML

Year: 2015
Type: review
Source: Current Opinion in Immunology
DOI: 10.1016/j.coi.2015.09.002
Authors: Allyson Spence, Joanna E Klementowicz, Jeffrey A Bluestone, Qizhi Tang
Institution: University of California, San Francisco
Language: English

Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: regulatory T cells, autoimmune disease, Treg stability, intracellular signaling networks, epigenetic regulation, Treg-targeted therapy, immunomodulation
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1144106772, CHARACTERIZATION OF AN INSULIN MEDIATOR PHOSPHOPROTEIN, G2364245107, G328839724, "Regulatory 'T' Cell Control of Autoimmune Diabetes"., Immunomodulation of transplant rejection by Anti-CD3 mAb, G6347265667, IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB, Diabetes Research Center, Cancer Center Support Grant
OpenAlex ID: W1776093990
FWCI: 0.87
Cites: 116
Cited by: 106
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security